Cargando…

Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study

Mesenchymal glioblastoma stem cells (GSCs), a subpopulation in glioblastoma that are responsible for therapy resistance and tumor spreading in the brain, reportedly upregulate aldehyde dehydrogenase isoform-1A3 (ALDH1A3) which can be inhibited by disulfiram (DSF), an FDA-approved drug formerly presc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zirjacks, Lisa, Stransky, Nicolai, Klumpp, Lukas, Prause, Lukas, Eckert, Franziska, Zips, Daniel, Schleicher, Sabine, Handgretinger, Rupert, Huber, Stephan M., Ganser, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615869/ https://www.ncbi.nlm.nih.gov/pubmed/34827559 http://dx.doi.org/10.3390/biom11111561

Ejemplares similares

Against Repurposing Methadone for Glioblastoma Therapy
por: Vatter, Tatjana, et al.
Publicado: (2020)

Alternating Electric Fields (TTFields) Activate Ca(v)1.2 Channels in Human Glioblastoma Cells
por: Neuhaus, Eric, et al.
Publicado: (2019)

Ion channels as molecular targets of glioblastoma electrotherapy
por: Abed, Tayeb, et al.
Publicado: (2023)

K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
por: Klumpp, Lukas, et al.
Publicado: (2018)

TRPM8 is required for survival and radioresistance of glioblastoma cells
por: Klumpp, Dominik, et al.
Publicado: (2017)

hERG K(+) Channels Promote Survival of Irradiated Leukemia Cells
por: Palme, Daniela, et al.
Publicado: (2020)

Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K(Ca)3.1 K(+) Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction
por: Stransky, Nicolai, et al.
Publicado: (2022)

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
por: Eckert, Franziska, et al.
Publicado: (2018)

Efficacy of combined tumor irradiation and K(Ca)3.1-targeting with TRAM-34 in a syngeneic glioma mouse model
por: Stransky, Nicolai, et al.
Publicado: (2023)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021)

Repurposing Disulfiram as an Antifungal Agent: Development of a New Disulfiram Vaginal Mucoadhesive Gel
por: Lajarin-Reinares, Maria, et al.
Publicado: (2023)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

Repurposing Disulfiram as an Antimicrobial Agent in Topical Infections
por: Lajarin-Reinares, Maria, et al.
Publicado: (2022)

Ion Channels in Brain Metastasis
por: Klumpp, Lukas, et al.
Publicado: (2016)

Reply to the Letter to the Editor by D. D’Arcangelo et al.: “Ion Channels in Brain Metastasis”—Ion Channels in Cancer Set up and Metastatic Progression Ion Channels in Brain Metastasis
por: Klumpp, Lukas, et al.
Publicado: (2017)

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
por: Zhang, Gong, et al.
Publicado: (2022)

BK K(+) channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells
por: Edalat, Lena, et al.
Publicado: (2016)

Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent
por: Shirley, Debbie-Ann, et al.
Publicado: (2021)

Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial
por: Jakola, Asgeir Store, et al.
Publicado: (2018)

Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing Strategy
por: Mandell, Jonathan B., et al.
Publicado: (2019)

Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo
por: Potula, Hari-Hara S. K., et al.
Publicado: (2020)

The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells
por: Rezaei, Narges, et al.
Publicado: (2020)

Comment on Chen et al. Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin. Biomolecules 2021, 11, 1373
por: Stransky, Nicolai, et al.
Publicado: (2022)

Can Any Drug Be Repurposed for Cancer Treatment? A Systematic Assessment of the Scientific Literature
por: Stransky, Nicolai, et al.
Publicado: (2021)

Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats
por: Omran, Ziad, et al.
Publicado: (2020)

Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors
por: Eckert, Franziska, et al.
Publicado: (2019)

Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor
por: Liu, Chan-Chuan, et al.
Publicado: (2021)

Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro
por: Koh, Hyeon Kang, et al.
Publicado: (2019)

Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia
por: Pfeiffer, Matthias Manuel, et al.
Publicado: (2013)

High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells
por: Hothi, Parvinder, et al.
Publicado: (2012)

Disulfiram Induced Psychosis
por: Mohapatra, Satyakam, et al.
Publicado: (2017)

Disulfiram Treatment of Alcoholism
por: Anton, Raymond F.
Publicado: (1995)

Encephalopathy caused by disulfiram
por: Sant’Angelo, R., et al.
Publicado: (2021)

Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
por: Sun, Ting, et al.
Publicado: (2020)

“Repurposing” Disulfiram in the Treatment of Lyme Disease and Babesiosis: Retrospective Review of First 3 Years’ Experience in One Medical Practice
por: Gao, Jiachen, et al.
Publicado: (2020)

Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma
por: Qiu, Chen, et al.
Publicado: (2020)

Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
por: Sun, Ting, et al.
Publicado: (2020)

In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment
por: Grote, Stefan, et al.
Publicado: (2021)

Ionizing radiation, ion transports, and radioresistance of cancer cells
por: Huber, Stephan M., et al.
Publicado: (2013)

Disulfiram—Mitigating Unintended Effects
por: Grout, Martha M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_237n9qskpqj0q3b860i387aqt7